<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DIMETHYL SULFOXIDE</span><br/>(dye-meth'il sul-fox'ide)<br/><span class="topboxtradename">DMSO, </span><span class="topboxtradename">Rimso-50<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">antiinflammatory</span>; <span class="classification">local</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>50% solution</p>
<h1><a name="action">Actions</a></h1>
<p>Mechanism of action not known.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Reported effects include antiinflammatory effects, membrane penetration, collagen dissolution, vasodilation, muscle relaxation,
         diuresis, weak bacteriostatic and antifungal actions, initiation of histamine release at administration site, cholinesterase
         inhibition.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Symptomatic treatment of interstitial cystitis.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Topical treatment of a variety of musculoskeletal disorders, arthritis, scleroderma, tendinitis, breast and prostate malignancies,
         retinitis pigmentosa, herpesvirus infections, head and spinal cord injuries, shock, and as a carrier to enhance penetration
         and absorption of other drugs. Also used to protect living cells and tissues during cold storage (cryo-protection). Widely
         used as an industrial solvent and in veterinary medicine for treatment of musculoskeletal injuries.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Safe use during pregnancy (category C), lactation, or in children is not established.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hepatic or renal dysfunction.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Interstitial Cystitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Instillation</span> 50 mL of 50% solution instilled slowly into urinary bladder and retained for 15 min; may repeat q2wk until maximum relief
               obtained, then increase intervals between treatments<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Instillation</span><br/><ul>
<li>Apply analgesic lubricant such as lidocaine jelly to urethra to facilitate insertion of catheter.</li>
<li>Instruct patient to retain instillation for 15 min and then expel it by spontaneous voiding.</li>
<li> 					Note: Discomfort associated with instillation usually lessens with repeated administration. Physician may prescribe an oral analgesic
            or suppository containing belladonna and an opiate prior to instillation to reduce bladder spasm. 				
         </li>
<li>Store at 15°30° C (59°86° F) unless otherwise directed. Protect from strong light. Avoid contact
            with plastics.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Special Senses:</span> Transient disturbances in color vision, photophobia. <span class="typehead">GI:</span> Nausea, diarrhea. Hypersensitivity: Local or generalized rash, erythema, pruritus, urticaria, swelling of face, dyspnea (<span class="speceff-life">anaphylactoid reaction</span>). <span class="typehead">Other:</span> Nasal congestion, headache, sedation, drowsiness.  <span class="typehead">Following instillation:</span> <span class="speceff-common">Garlic-like odor on breath and skin; garlic-like taste;</span> discomfort during administration; transient cystitis. <span class="typehead">Following topical application:</span> Vesicle formation. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  Decreases effectiveness of <b>sulindac,</b> possibly causing severe peripheral neuropathy. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed systemically. <span class="typehead">Peak:</span> 48 h. <span class="typehead">Distribution:</span> Widely distributed in tissues and body fluids; penetrates bloodbrain barrier; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized to dimethyl sulfide (garlic breath) and dimethyl sulfone. <span class="typehead"> Elimination:</span> Dimethyl sulfide excreted through lungs and skin; dimethyl sulfone may remain in serum &gt;2 wk and is excreted in urine and
      feces. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Do CBC and liver and renal function tests initially and at 6-mo intervals.</li>
<li>Do complete eye evaluation including slit-lamp examination prior to and at regular intervals during therapy.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li> 								Note: Garlic-like taste may be experienced within minutes after drug instillation and may last for several hours. Garlic-like odor
            on breath and skin may last as long as 72 h. 							
         </li>
<li>Do not use OTC topical medications without consulting physician.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>